Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment

Abroad (travel likely)RecruitingPHASE3

Conditions

Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Jia-Yi Chen, M.D.) · chenjiayi0188@aliyun.com · +86-021-64370045
Contact: Study coordinator (Jia-Yi Chen, M.D) · chenjiayi0188@aliyun.com · +86-021-64370045

Study leads

Jia-Yi Chen
Study Chair
Ruijin Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation · HER2- Negative Breast Cancer · Hormone Receptor Positive Tumor

Abroad (travel likely)RecruitingPHASE3

Gilbert, United States · Beverly Hills, United States

Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms · Locally Advanced or Metastatic Breast Cancer

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China · Hunan, China

TCb vs EC-T in High Risk ER+/HER2- Breast Cancer

Hormone Receptor Positive HER-2 Negative Breast Cancer

Abroad (travel likely)RecruitingPHASE3

Shanghai, China

Skipping Hormone Therapy in Low-Risk Early Breast Cancer

Breast Cancer (Early Breast Cancer)

Abroad (travel likely)RecruitingPHASE2

Angers, France · Avignon, France